The use of glycoprotein IIb/IIIa receptor antagonists in percutaneous coronary intervention results in both short- and long-term benefits

Author： Adis International Limited

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.20, Iss.10, 2004-10, pp. : 7-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycoprotein IIb/IIIa Receptor Antagonists: A Comparative Review of Their Use in Percutaneous Coronary Intervention

By Nguyen C.M. Harrington R.A.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 6, 2003-01 ,pp. : 423-436

Adis International

Access to resources Recommend Favorite

Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneous Coronary Interventions

By Starnes H. Benjamin Patel Ankit A. Stouffer George A.

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2009-2030

Adis International

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists in Non-ST Elevation Acute Coronary Syndromes and Percutaneous Revascularisation: A Review of Trial Reports

By Kong D.F.

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 609-620

Adis International

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Receptor Antagonists And Their Use In Elderly Patients

By Mak K-H.

Drugs & Aging, Vol. 16, Iss. 3, 2000-03 ,pp. : 179-187

Adis International

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary Syndromes: Estimating the Economic Implications

By Hillegass W.B.

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 41-55

Adis International

Access to resources Recommend Favorite